ArticleCellular and molecular life sciences : CMLS2026
HAdV55 reprograms host 3D genome architecture and mitochondrial metabolism to drive pathogenesis.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Human adenovirus type 55 (HAdV55), an emerging recombinant pathogen linked to severe respiratory outbreaks, exhibits heightened virulence and replication efficiency, yet its mechanisms of host interaction remain poorly resolved. Here, we integrate transcriptomic and 3D genomic analyses to define the spatiotemporal interplay between HAdV55 and A549 cells. Temporal profiling revealed triphasic host transcriptional reprogramming, with distinct clusters of genes governing cell survival, apoptosis, and innate immunity dynamically modulated during infection. Crucially, HAdV55 reshapes the 3D chromatin architecture, inducing compartmental shifts on chromosome 15 (A-to-B transitions at 72-96 h) and selectively localizing its genome to transcriptionally active chromatin regions. Strikingly, the viral genome exhibits progressive interactions with mitochondrial energy metabolism genes (ATP6, ND1, CYB), suggesting mitochondrial hijacking to fuel replication. Functional validation via gene silencing identified ABL2, FANCI, STK4, TRIM24, TRIM2 and MAPK10 as critical host regulators restricting viral proliferation, with knockdowns amplifying viral loads over to 15-fold. This study also establishes, for the first time, a spatial link between adenoviral infection and mitochondrial genome dynamics, offering a paradigm for investigating virus-host interactions in three-dimensional genomic contexts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.